indazoles has been researched along with Cerebral Hemorrhage in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, G; Kong, L; Liu, C; Liu, N; Ma, G; Ma, Y; Shi, R; Wang, Z | 1 |
| Fehnel, CR; Miller-Patterson, C | 1 |
2 other study(ies) available for indazoles and Cerebral Hemorrhage
| Article | Year |
|---|---|
Inhibition of hypoxia inducible factor 1 by YC-1 attenuates tissue plasminogen activator induced hemorrhagic transformation by suppressing HMGB1/TLR4/NF-κB mediated neutrophil infiltration in thromboembolic stroke rats.
Topics: Animals; Brain Ischemia; Cerebral Hemorrhage; Endothelial Cells; HMGB1 Protein; Hypoxia-Inducible Factor 1; Indazoles; Male; Neutrophil Infiltration; NF-kappa B; Platelet Aggregation Inhibitors; Rats, Sprague-Dawley; Stroke; Thromboembolism; Tissue Plasminogen Activator; Toll-Like Receptor 4 | 2021 |
Pazopanib-associated posterior reversible encephalopathy syndrome with intracerebral haemorrhage.
Topics: Aged; Carcinoma, Renal Cell; Cerebral Hemorrhage; Decompressive Craniectomy; Female; Humans; Indazoles; Kidney Neoplasms; Magnetic Resonance Imaging; Posterior Leukoencephalopathy Syndrome; Pyrimidines; Sulfonamides; Treatment Outcome | 2017 |